Favorable Response to Sirolimus in a Child With Blue Rubber Bleb Nevus Syndrome in the Gastrointestinal Tract

J Pediatr Hematol Oncol. 2017 Mar;39(2):147-149. doi: 10.1097/MPH.0000000000000681.

Abstract

Recently, sirolimus was demonstrated to be effective in treating vascular lesions and lessening the frequency of bleeding and secondary iron deficiency anemia. We present a child with blue rubber bleb nevus syndrome who had prolonged history of iron deficiency anemia secondary to unrecognized gastrointestinal bleeding. Treatment with propranolol, omeprazole and iron had failed. After 2.5 months of sirolimus therapy (trough levels 1 to 5 ng/mL), his hemoglobin concentration improved into the normal range and remained stable. Vascular malformations on both the patient's tongue and in the fundus of his stomach shrank within 5 months of the initiation of sirolimus. In gastrointestinal involvement of blue rubber bleb nevus syndrome sirolimus was found to be effective even in the tongue's vascular lesions.

Publication types

  • Case Reports

MeSH terms

  • Abnormalities, Multiple
  • Anemia, Iron-Deficiency / etiology
  • Child
  • Consanguinity
  • Gastrointestinal Hemorrhage / etiology
  • Gastrointestinal Neoplasms / complications
  • Gastrointestinal Neoplasms / drug therapy*
  • Heart Septal Defects, Atrial / complications
  • Humans
  • Male
  • Neoplasms, Multiple Primary / complications
  • Neoplasms, Multiple Primary / drug therapy*
  • Nevus, Blue / complications
  • Nevus, Blue / drug therapy*
  • Oral Ulcer / chemically induced
  • Sirolimus / adverse effects
  • Sirolimus / therapeutic use*
  • Skin Neoplasms / complications
  • Skin Neoplasms / drug therapy*
  • Tongue Neoplasms / drug therapy

Substances

  • Sirolimus

Supplementary concepts

  • Blue rubber bleb nevus syndrome